- ¥494bn
- ¥491bn
- ¥110bn
- 87
- 27
- 94
- 83
Annual balance sheet for Dexerials, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2021 March 31st | C2022 March 31st | 2023 March 31st | R2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 20,531 | 29,363 | 29,286 | 35,388 | 35,105 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 12,794 | 19,427 | 13,466 | 15,588 | 17,979 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 43,259 | 65,086 | 59,238 | 69,442 | 63,559 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 22,635 | 26,703 | 32,284 | 37,390 | 49,703 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 95,201 | 128,785 | 126,379 | 140,373 | 151,821 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 25,552 | 49,803 | 35,074 | 33,692 | 39,270 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 41,896 | 65,049 | 53,483 | 55,251 | 55,906 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 53,305 | 63,736 | 72,896 | 85,122 | 95,915 |
| Total Liabilities & Shareholders' Equity | 95,201 | 128,785 | 126,379 | 140,373 | 151,821 |
| Total Common Shares Outstanding |